Presentation TCT 2014 The Emphatic Case for OPCs NOW for New DES Approval in the United States! Presenter: Andrew Farb, Mitchell W. Krucoff, Aaron V. Kaplan, Laura Mauri September 16, 2014
Presentation TCT 2014 Device Approval Considerations (Preclinical and Clinical) for Bioresorbable Scaffolds: Update on FDA Regulatory Guidelines Presenter: Andrew Farb, Mitchell W. Krucoff, Aaron V. Kaplan, Kenya Brothers September 16, 2014
Presentation TCT 2014 LAA Occlusion Devices Stuck in the Mud Matching the Right Patients with the Best Trial Designs (and Endpoints) Presenter: Matthew G. Hillebrenner, Gregg W. Stone, Matthew J. Price, Brian K. Whisenant September 16, 2014
Presentation TCT 2014 Are the Current Clinical Trial Pathways for New Mitral Valve Therapies Practical? A Future Roadmap to Consider! Presenter: Matthew G. Hillebrenner, Michael J. Mack, Francesco Maisano, Gregg W. Stone September 16, 2014
Presentation TCT 2014 Mitral Valve Repair vs Replacement: Complementary or Competitive? Presenter: Matthew G. Hillebrenner, Michael J. Mack, Francesco Maisano September 16, 2014
Presentation TCT 2014 What Is the Clinical Trial Pathway Moving Forward for Renal Denervation? Presenter: Ajay J. Kirtane, Bram D. Zuckerman, Paul A. Sobotka September 16, 2014
Presentation TCT 2014 Global Perspectives in the Post-HTN-3 Era: A Kinder and Gentler Interpretation of Renal Denervation Therapy Presenter: Ajay J. Kirtane, Bram D. Zuckerman, Paul A. Sobotka, Felix Mahfoud September 16, 2014
Presentation TCT 2014 New Insights from SYMPLICITY HTN-3 What I Learned and What I Would Have Done Differently Presenter: Ajay J. Kirtane, Bram D. Zuckerman, Paul A. Sobotka, Deepak L. Bhatt September 16, 2014
Presentation TCT 2014 TAVR Controversies: Strokes and Paravalvular Regurgitation Will New TAVR Systems or Accessory Devices Make a Difference? Presenter: Matthew G. Hillebrenner, Michael J. Mack, Daniel I. Simon, Samir R. Kapadia September 16, 2014
Presentation TCT 2014 Regulatory Approval Pathways for Novel vs Iterative TAVR Devices: Back to the Future? Presenter: Matthew G. Hillebrenner, Michael J. Mack, Daniel I. Simon, Nicole Ibrahim September 16, 2014
Presentation TCT 2014 A Golden Year for TAVR - Accomplishments, Controversies, and Future Directions Presenter: Matthew G. Hillebrenner, Michael J. Mack, Daniel I. Simon, Martin B. Leon September 16, 2014
Presentation TCT 2014 Clinical Indications for TAVR: Where are We and Where are We Going? Presenter: Matthew G. Hillebrenner, Michael J. Mack, Daniel I. Simon, A. Pieter Kappetein September 16, 2014
News Industry News Randomized Study Demonstrates the Superiority of Laser Atherectomy for Treatment of In-Stent Restenosis in Patients with Femoropopliteal Peripheral Artery Disease September 16, 2014
News Industry News Randomized Sham-Controlled Trial Examines Blood Pressure Effects of Renal Denervation in Patients with Mild Refractory Hypertension September 16, 2014
News Industry News New Study Examines the Effect of Percutaneous Patient Foramen Ovale Closure on Migraine Headaches September 16, 2014
News Industry News New Study Evaluates the Safety and Efficacy of Biodegradable Polymer-Coated Sirolimus-Eluting Stents in Patients with Coronary Artery Disease September 16, 2014
News Industry News New All-Comers Study Compares Efficacy of Bioresorbable Vascular Scaffold to Best-in-Class Drug Eluting Stents September 16, 2014
News Conference News TCT 2014 First TCT Innovation Award Given for Novel Cooling System September 16, 2014
News Industry News Clinical Trial Results for Impella RP Right Ventricular Heart Failure Trial, RECOVER RIGHT, Released at TCT 2014 September 16, 2014
News Conference News TCT 2014 Marco Barbanti, MD, Receives Linnemeier Young Investigator Award September 16, 2014